Moxifloxacin + Prednisolone AcetateThird Party Manufacturing in India
Looking to get Moxifloxacin + Prednisolone Acetate manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
Moxifloxacin + Prednisolone Acetate works through dual target inhibition. Moxifloxacin targets bacterial topoisomerase complexes to stop bacterial growth, while prednisolone acetate halts arachidonic acid pathways to reduce ocular inflammation. Unlike alternative classes with lower tissue penetration, it rapidly crosses the corneal epithelium to manage severe segment inflammation. It is highly effective and well-tolerated.
Therapeutic Uses & Indications
Therapeutic Uses
- Severe Conjunctival Inflammation: Alleviation of intensive tissue swelling accompanied by active bacterial eye infection.
- Post-Surgical Trauma: Prophylactic treatment following structural corneal surgeries to minimize scarring risks.
Why Manufacturers Choose Moxifloxacin + Prednisolone Acetate
This high-potency combination remains a top procurement priority, making Moxifloxacin + Prednisolone Acetate third party manufacturing in India an essential addition for leading brands. Our production facilities maintain comprehensive WHO-GMP accreditation, ensuring pristine batch uniformity. Backed by authenticated bulk supply under CAS number 151096-09-2, this eye drop formulation stands out for its optimal suspension particle size and clinical reliability.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Moxifloxacin + Prednisolone Acetate?
What dosage forms of Moxifloxacin + Prednisolone Acetate can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Moxifloxacin + Prednisolone Acetate for export?
What grade standards do you follow for Moxifloxacin + Prednisolone Acetate?
Get Moxifloxacin + Prednisolone Acetate made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- MOQ from 12,000 bottles per batch
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
Sterile 5ml dropper bottles with child-resistant caps. Packaging customized to client brand guidelines.
Start Manufacturing Moxifloxacin + Prednisolone Acetate Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Moxifloxacin + Prednisolone Acetate across all dosage forms. PCD franchise and export orders welcome.